Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C
- 30 May 2001
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 72 (1-3) , 217-224
- https://doi.org/10.1016/s0168-3659(01)00277-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis CAnnals of Internal Medicine, 2000
- Biopharmaceutical Properties of Uricase Conjugated to Neutral and Amphiphilic PolymersBioconjugate Chemistry, 1999
- Accelerated Clearance of Polyethylene Glycol-Modified Proteins by Anti-Polyethylene Glycol IgMBioconjugate Chemistry, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- A Branched Monomethoxypoly(ethylene glycol) for Protein ModificationBioconjugate Chemistry, 1995
- Distribution and Tissue Uptake of Poly(ethylene glycol) with Different Molecular Weights after Intravenous Administration to MiceJournal of Pharmaceutical Sciences, 1994
- The therapeutic value of poly(ethylene glycol)-modified proteinsAdvanced Drug Delivery Reviews, 1991
- Proton NMR characterization of poly(ethylene glycols) and derivativesMacromolecules, 1990
- Effects of Coupling Chemistry on the Activity of Poly(ethylene glycol)-Modified Alkaline PhosphataseJournal of Bioactive and Compatible Polymers, 1989
- LABORATORY SYNTHESIS OF POLYETHYLENE GLYCOL DERIVATIVESJournal of Macromolecular Science, Part C: Polymer Reviews, 1985